Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FU.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FU.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FU.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FU.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FV.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GJ.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.22.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
P.2 (Zeta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.2 (Zeta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.2 (Zeta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.2 (Zeta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.2 (Zeta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.2 (Zeta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.2 (Zeta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.2 (Zeta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used